A detailed history of Deutsche Bank Ag\ transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 58,113 shares of KOD stock, worth $359,719. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,113
Previous 58,094 0.03%
Holding current value
$359,719
Previous $136,000 11.03%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.2 - $3.25 $41 - $61
19 Added 0.03%
58,113 $151,000
Q2 2024

Aug 14, 2024

SELL
$2.29 - $4.48 $5,704 - $11,159
-2,491 Reduced 4.11%
58,094 $136,000
Q1 2024

May 15, 2024

SELL
$3.01 - $7.45 $35,611 - $88,140
-11,831 Reduced 16.34%
60,585 $318,000
Q4 2023

Feb 14, 2024

BUY
$1.4 - $3.24 $96,196 - $222,626
68,712 Added 1855.08%
72,416 $220,000
Q3 2023

Nov 09, 2023

SELL
$1.8 - $7.49 $94,233 - $392,116
-52,352 Reduced 93.39%
3,704 $6,000
Q2 2023

Aug 14, 2023

SELL
$4.3 - $9.48 $113,004 - $249,134
-26,280 Reduced 31.92%
56,056 $386,000
Q1 2023

May 15, 2023

SELL
$4.81 - $8.88 $141,457 - $261,151
-29,409 Reduced 26.32%
82,336 $510,000
Q4 2022

Feb 13, 2023

SELL
$6.52 - $8.05 $174,383 - $215,305
-26,746 Reduced 19.31%
111,745 $800,000
Q3 2022

Nov 14, 2022

BUY
$7.57 - $12.5 $622,867 - $1.03 Million
82,281 Added 146.38%
138,491 $1.07 Million
Q2 2022

Aug 11, 2022

BUY
$5.04 - $9.48 $13,285 - $24,989
2,636 Added 4.92%
56,210 $429,000
Q1 2022

May 13, 2022

BUY
$7.09 - $89.45 $218,471 - $2.76 Million
30,814 Added 135.39%
53,574 $413,000
Q4 2021

Feb 11, 2022

SELL
$80.85 - $128.49 $49,561 - $78,764
-613 Reduced 2.62%
22,760 $1.93 Million
Q3 2021

Nov 04, 2021

BUY
$81.97 - $106.94 $48,772 - $63,629
595 Added 2.61%
23,373 $2.24 Million
Q2 2021

Aug 11, 2021

SELL
$77.2 - $126.54 $101,826 - $166,906
-1,319 Reduced 5.47%
22,778 $2.12 Million
Q1 2021

May 13, 2021

SELL
$110.45 - $164.47 $243,763 - $362,985
-2,207 Reduced 8.39%
24,097 $2.73 Million
Q4 2020

Feb 16, 2021

BUY
$60.78 - $154.03 $529,697 - $1.34 Million
8,715 Added 49.55%
26,304 $3.86 Million
Q3 2020

Nov 12, 2020

BUY
$45.05 - $59.27 $54,195 - $71,301
1,203 Added 7.34%
17,589 $1.04 Million
Q2 2020

Aug 13, 2020

BUY
$42.74 - $66.25 $139,033 - $215,511
3,253 Added 24.77%
16,386 $887,000
Q1 2020

May 14, 2020

BUY
$38.18 - $73.95 $162,761 - $315,248
4,263 Added 48.06%
13,133 $627,000
Q4 2019

Feb 14, 2020

BUY
$13.9 - $76.65 $26,006 - $143,412
1,871 Added 26.73%
8,870 $637,000
Q3 2019

Nov 14, 2019

SELL
$10.24 - $17.57 $403,322 - $692,029
-39,387 Reduced 84.91%
6,999 $98,000
Q2 2019

Aug 14, 2019

BUY
$6.2 - $12.0 $211,389 - $409,140
34,095 Added 277.4%
46,386 $541,000
Q1 2019

May 15, 2019

SELL
$6.43 - $9.44 $855 - $1,255
-133 Reduced 1.07%
12,291 $78,000
Q4 2018

Feb 14, 2019

BUY
$6.11 - $10.43 $75,910 - $129,582
12,424 New
12,424 $87,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $322M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.